Device Trial Radar · NCT07764614
Tornier Perform™ Reversed Monopost Study
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Oct 22, 2026
Primary completion
Dec 30, 2030
Study completion Aug 30, 2031
Sponsor
- Lead sponsor
- Stryker Trauma and ExtremitiesPublic (SYK)
- Sponsor type
- Industry
- First posted
- Aug 14, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Multi-center, Prospective Follow-up, Non-significant risk, Post-Market Clinical Follow-Up (PMCF) study to Evaluate the Safety and Effectiveness of the Tornier Perform™ Reversed MonoPost System.
Conditions
- Non-inflammatory Degenerative Joint Disease
- Rhematoid Arthritis
- Correction of Functional Deformity
- Fracture of the Humeral Head
- Traumatic Arthritis
- Revision of the Devices if Sufficient Bone Stock Remains
Interventions
Tornier Perform™ Reversed MonoPostDevice
The Commercially available Tornier Perform™ Reversed MonoPost Glenoid is intended to replace the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance: American Shoulder and Elbow Surgeons (ASES) score- change in functional ability of the treated shoulderTime frame: from baseline to 2 years
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Eisenhower Health
Rancho Mirage, California · Recruiting
Washington University
St Louis, Missouri · Recruiting
Ohio State University
Columbus, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.